Lumentum Holdings Inc.: Form 10-Q for the period ended Mar 31, 2018
Filed with the SEC on May 2, 2018 and accepted by EDGAR at May 2, 2018, 09:26 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Gross profit | 3 months2017-12-31 to 2018-03-31 | $97.0m | us-gaap:GrossProfit |
| Gross profit | 9 months2017-07-02 to 2018-03-31 | $336.6m | us-gaap:GrossProfit |
| Research and development | 3 months2017-12-31 to 2018-03-31 | $38.2m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2017-07-02 to 2018-03-31 | $118.3m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2017-12-31 to 2018-03-31 | $33.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2017-07-02 to 2018-03-31 | $95.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2017-12-31 to 2018-03-31 | $25.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2017-07-02 to 2018-03-31 | $119.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2017-12-31 to 2018-03-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2017-07-02 to 2018-03-31 | −$112.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-12-31 to 2018-03-31 | $2.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months2017-07-02 to 2018-03-31 | $214.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-12-31 to 2018-03-31 | $0.04 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2017-07-02 to 2018-03-31 | $3.31 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-12-31 to 2018-03-31 | $0.04 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2017-07-02 to 2018-03-31 | $3.37 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-12-31 to 2018-03-31 | 63,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2017-07-02 to 2018-03-31 | 63,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2017-07-02 to 2018-03-31 | $209.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2017-07-02 to 2018-03-31 | $72.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2018-03-31 | $176.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-03-31 | $1.06bn | us-gaap:AssetsCurrent |
| Total assets | At period end2018-03-31 | $1.52bn | us-gaap:Assets |
| Current liabilities | At period end2018-03-31 | $191.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-03-31 | $605.8m | us-gaap:Liabilities |
| Long-term debt | At period end2018-03-31 | $456.1m | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2018-03-31 | $876.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001633978-18-000030. Last ingested by Listed: Nov 11, 2026, 00:26 ET. Listed shows no prices and gives no investment advice.